Answer
Femoston 1/10 mg provides HRT for oestrogen-deficiency symptoms in postmenopausal women at least six months after their last period and prevents osteoporosis in those at high fracture risk who cannot tolerate or have contraindications to other approved osteoporosis-prevention medicines; experience in women over 65 is limited.
Sources for this answer
- Femoston 1/10mg film-coated tabletsExeltis UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 29Document updated
Sources checked